Costimulation, Coinhibition and Cancer
Journal:
Current Cancer Drug Targets
Volume:
7
Page:
15-30
Author(s):
Brant A. Inman, Xavier Frigola, Haidong Dong and Eugene D. Kwon
Indoleamine 2,3-Dioxygenase in Immune Suppression and Cancer
Journal:
Current Cancer Drug Targets
Volume:
7
Page:
31-40
Author(s):
Alexander J. Muller and George C. Prendergast
Tyrosine Kinase Mutations in Human Cancer
Journal:
Current Molecular Medicine
Volume:
7
Page:
77-84
Author(s):
Ernst Lengyel, Kenjiro Sawada and Ravi Salgia
Subject Index To Volume 6
Journal:
Current Molecular Medicine
Volume:
7
Page:
v-xv
Author(s):
Editorial [ Hot Topic: Novel Targets for Cancer Therapy (Executive Editor: E. Bergmann-Leitner) ]
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
445-446
Author(s):
E. Bergmann-Leitner
NF-κB Signaling and Carcinogenesis
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
447-462
Author(s):
Takashi Okamoto, Takaomi Sanda and Kaori Asamitsu
Targeting Different Signaling Pathways with Antisense Oligonucleotides Combination for Cancer Therapy
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
463-470
Author(s):
C. Leonetti and G. Zupi
Novel Therapeutic Approaches Based on the Targeting of Microenvironment-Derived Survival Pathways in Human Cancer: Experimental Models and Translational Issues
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
487-496
Author(s):
Pierfrancesco Tassone, Pierosandro Tagliaferri, Maria Teresa Fulciniti, Maria Teresa Di Martino and Salvatore Venuta
Targeted Therapy of Breast Cancer
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
497-517
Author(s):
Raffaele Longo, Francesco Torino and Giampietro Gasparini
Current Concepts for the Combined Treatment Modality of Ionizing Radiation with Anticancer Agents
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
519-535
Author(s):
Christoph Oehler, Daniel J. Dickinson, Angela Broggini-Tenzer, Barbara Hofstetter, Andreas Hollenstein, Oliver Riesterer, Van Vuong and Martin Pruschy